Logo of Marie Skłodowska-Curie Actions

MSCA Fellowship in the use of Integrated Tools for Maximising Stability of Customised Pharmaceutical Formulations

This hosting has expired

    03/07/2020 00:00 - Europe/London
    H2020 / Marie Skłodowska-Curie Actions
    United Kingdom, Wolverhampton
    University of Wolverhampton
    The Faculty of Science and Engineering

The University of Wolverhampton is a leading modern university with a tradition of providing opportunity and academic excellence dating back nearly 190 years. The University has a dynamic research community with a thirst for knowledge. Research underpins learning, teaching and business at the University and is at the heart of everything it does. In the most recent Research Excellence Framework (REF 2014), the University of Wolverhampton achieved its best ever results with 41% of the submission graded as world-leading or internationally excellent; and the university offer researchers an outstanding research environment to carry out their project. The University of Wolverhampton strives to attract and nurture talented scholars across the world, delivering cutting-edge research emerging the STEM disciplines. The University’s Research Investment Fund (RIF) is an annual allocation of £2 million committed to a series of strategic projects and initiatives over a 3 year period, designed to enhance our research excellence and support the periodic Research Excellence Framework (REF) assessments. RIF4 is now running and will cover the period from 2020 to 2023. Notable results of this research drive have included: the establishment of the UK’s leading centre in War Studies; key work on brain signal responses in Parkinson’s disease sufferers and the development of a coating for probiotics to enable better absorption in the gut.

The faculty of science and Engineering at the University of Wolverhampton invites an expression of interest from applicants with a good research track record for a Marie Sklodowska-Curie Individual Fellowship. The successful candidate will be supported by a group of interdisciplinary team members to develop innovative research proposal at the interface of engineering, biology and pharmaceutical science. The Fellowship position will be hosted by the University of Wolverhampton, UK under the 2020 Marie Skłodowska-Curie Actions (MSCA) Individual Fellowships (IF) 20220 Call. The Marie Sklodowska-Curie Actions Individual Fellowships 2020 Guide for Applicants is available at: https://ec.europa.eu/research/participants/data/ref/h2020/other/guides_f...

The Marie Sklodowska-Curie actions support researchers at all stages of their careers, regardless of age and nationality.

This Marie Curie Fellowship is designed to promote excellence in research and to foster the exchange of knowledge provides the opportunity for researchers who comply with the mobility rules to present a 24 months proposal.

Experienced Researchers in possession of PhD or more then 4 years reaserach experience in STEM (Science, Technology, Engineering, or Mathematics) required with good track record of publications.

Researchers shall, at the time of the deadline for submission of proposals, be in possession of a doctoral degree or have at least four years of full-time equivalent research experience (measured from the date when he/she obtained the degree formally entitling him or her to embark on a doctorate).

The fellow should have research experience and a publication track record in at least two of the following areas: formulation engineering and stability, encapsulation and actives (e.g. peptides/proteins) stability in vitro with degradation kinetics, release kinetics and bioactivity evaluation, rheology and tribology/nanotribology.

The fellow should have developed research experience in international research groups.



The responsibility for the hosting offers published on this website, including the hosting description, lies entirely with the publishing institutions. The application is handled uniquely by the employer, who is also fully responsible for the recruitment and selection processes.